Quantcast

Latest Biomarker Stories

2014-07-10 23:01:03

Scientists from around the world will gather in Copenhagen to release the latest findings in research on diagnostics, treatments, biomarkers, risk factors, and the potential for reducing risks. Denver, Colorado (PRWEB) July 10, 2014 Thousands of researchers from more than 60 countries will gather in Copenhagen this July 13-17 to reveal the latest study results, theories and discoveries bringing the world closer to breakthroughs in dementia science. The Alzheimer’s Association...

2014-07-10 12:30:06

TUCSON, Ariz., July 10, 2014 /PRNewswire/ -- Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, today announced it has entered into an agreement with Merck KGaA, Darmstadt, Germany, which operates as EMD Serono in the United States and Canada, to collaborate with Merck KGaA's biopharmaceutical division on the development and commercialization of a companion diagnostic (CDx) for an undisclosed target using Ventana's proprietary diagnostic assays. In alignment with...

2014-07-07 15:58:52

European League Against Rheumatism Early detection could help prevent severe disease in the most common form of arthritis The results of a study presented today at the European League Against Rheumatism Annual Congress (EULAR 2014) identify a correlation between the presence of biomarkers in the blood, known as micro RNAs (miRNAs), and the development of severe osteoarthritis (OA) of the knee or hip joint. The findings suggest that miRNAs may be used as biomarkers to predict severe OA...

2014-07-07 08:27:28

VISTA, Calif. and HARTFORD, Conn., July 7, 2014 /PRNewswire/ -- AutoGenomics, Inc, a leader in automated microarray technology for molecular diagnostics, and Genomas, a biomedical company enabling DNA-guided medicine for personal healthcare, announced today that they have signed an agreement to jointly develop genetic tests and DNA-guided diagnostic systems for optimal selection of statins and for improved delivery of statin therapy for the treatment of cardiovascular disease, obesity...

2014-07-03 23:00:57

Transparency Market Research has announced the addition of the "Molecular Diagnostics Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019" report to their offering. Browse the full report: http://www.transparencymarketresearch.com/molecular-diagnostics-industry.html. Albany, New York (PRWEB) July 04, 2014 Molecular diagnostics is the class of diagnostic test that explores and evaluates nucleic acids or proteins at a molecular level. Our...

2014-07-01 16:30:01

CASTLE ROCK, Colo., July 1, 2014 /PRNewswire/ -- Venaxis, Inc. (Nasdaq: APPY), an in vitro diagnostic company focused on obtaining FDA clearance and commercializing its CE Marked APPY1(TM) Test, a rapid, multiple biomarker-based assay for identifying patients that are at low risk for appendicitis, today announced it will participate in the third annual ICV Company Outreach Summit, being held July 9-10, 2014, in Montauk, New York. Steve Lundy, President and CEO of Venaxis® will be...

2014-06-28 23:01:17

This metabolomics industry 2014-2019 research report, available with LifeScienceIndustryResearch.com is segmented based on techniques, applications, indications, geographic regions, and countries. It says the global metabolomics market was valued at $565 million in 2014 and is expected to grow at a CAGR of 30% from 2014 to 2019. Dallas, TX (PRWEB) June 28, 2014 Metabolomics Market by Technique (Gas Chromatography, High Performance Liquid Chromatography, Nuclear Magnetic Resonance...

2014-06-27 23:06:32

Researchers have pinpointed four key biomarkers they say could lead to earlier and more accurate diagnosis of pleural mesothelioma. Raleigh, NC (PRWEB) June 27, 2014 Scientists at Copenhagen University in Denmark say tiny cell components called microRNAs could help doctors distinguish malignant pleural mesothelioma from non-cancerous conditions and start treatment earlier. Surviving Mesothelioma has just posted an article on this important discovery. Click here to read it now. Researchers...

2014-06-26 23:14:34

The webinar will focus on gaining more predictive results in anti-cancer drug discovery on July 10th, 2014. Yorba Linda, CA (PRWEB) June 26, 2014 PerkinElmer just announced that their new webinar, “More Predictive Results in Cell-Based Assays: Combining Target-Based & Phenotypic Approaches Using the New EnSight Plate Reader,” will feature guest speaker Dr. Philip Gribbon, the Chief Scientific Officer at the European ScreeningPort (ESP). Dr. Gribbon has incorporated Perkin...

2014-06-25 08:30:31

LOUISVILLE, Ky., July 25, 2014 /PRNewswire/ -- Neuronetrix will be reporting at AAIC 2014 that neuro-electrophysiological measures recorded using the company's COGNISION(TM) System can be used to differentiate patients with mild Alzheimer's disease from healthy controls. Previous scientific studies have demonstrated the discriminatory power of these measures in highly controlled research environments. Neuronetrix's study demonstrated that these measures can be reliably recorded and...


Word of the Day
callithump
  • A somewhat riotous parade, accompanied with the blowing of tin horns, and other discordant noises; also, a burlesque serenade; a charivari.
'Callithump' is a back-formation of 'callithumpian,' a 'fanciful formation' according to the Oxford English Dictionary. However, the English Dialect Dictionary, says 'Gallithumpians' is a Dorset and Devon word from the 1790s that refers to 'a society of radical social reformers' or 'noisy disturbers of elections and meetings.'
Related